Navigation Links
RU-486, The Abortion Pill, May Quell The Breast Cancer Gene

The abortion drug RU-486 was used by scientists in mice that were bred with a breast cancer gene. The drug turned beneficial in warding off potential tumors.//

This is thought to have been possible due to the abortion drug, known to inhibit the hormone, progesterone. This is indeed a teaser to researchers to evolve a safe version of the hormone blocker as an option for women carrying the breast cancer gene.

Cell biologist Eva Lee of the University of California, Irvine, who led the research said, 'All of us have to be cautious. But I do think if there is a better anti-progesterone available, hopefully there will be other options in the future for these women.'

This has certainly raised the curiosity of the scientists who could translate the success in the mouse model and reflect it on better drugs for humans. Once scientists are able to nail how BRCA1 actually causes tumors, it will enable the knowledge to tide over the bad effects of BRCA1.

As part of the research, Lee and colleagues nurtured mice whose mammary glands accommodated only the BRCA1 mutation. Scientists actually found that the bad gene, which caused breast cancers, was also responsible in the breast tissue portraying high levels of progesterone receptors. The final proof came from RU-486, also known as mifepristone. It triggers human abortions by inhibiting progesterone, a hormone that is extremely important to support pregnancy.

In the experiment, Lee implanted a pellet of RU -486 in some of the cancer-susceptible mice; the drug would gradually be released into their bodies, over a period of two months. The finding revealed that within 8 months of age, the mice that were not treated, developed tumors. But the mice which were given RU-486 had not developed tumors at the end of the year. But researchers left a warning, that prolonged use of RU-486 is not recommended. Other varieties of progesterone-blockers which are safe for prolonged use are in the process of being developed.
SAV
'"/>




Related medicine news :

1. Abortion Pill approved by FDA
2. Abortion made easy pill causes alarm in state
3. Treatment for fibroids with "Abortion Pill"
4. Abortion may cause mental illness
5. Abortion Does Not Increase Risk Of Depression In Women
6. Teenage Girls May Not Need Parents Consent For Abortion
7. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
8. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
9. Mother Claims Hefty Compensation For Failed Abortion Of Twins
10. Abortions does not increase risk of breast cancer
11. Bill to Ban Abortion In Indiana Introduced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... ... February 10, 2016 , ... Gout is like no other ... that is often severe, with intense swelling and redness. It is triggered by the ... but older adults are the most susceptible, according to the February 2016 issue of ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association for ... speaker Jan Fox will serve as keynote speaker at the organization’s 2016 Spring ... tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... it will attend the Ohio Safety Congress and Expo event March 9-11, 2016. ... the Greater Columbus Convention Center. , As the longest running and largest ...
(Date:2/10/2016)... Middleboro, MA (PRWEB) , ... February 10, 2016 ... ... of their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns ... to provide a solution that ensures the integrity of biological samples while operating ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... SEATTLE , Feb. 10, 2016  Resolve ... potentially transformative new approaches to the treatment of ... completion of a multiple ascending dose study in ... lead compound RSLV-132. --> ... double-blind, placebo-controlled multiple ascending dose study of RSLV-132 ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the market ... treatment of Benign Prostatic Hyperplasia (BPH), announces new private ... Keswani , a medical device industry veteran of more ... Limited Liability Company.  Plymouth, Minn. ... lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will continue ...
Breaking Medicine Technology: